A phase 1 dose-escalation study of SLV-154 in subjects with metastatic solid tumors

Disease:

Squamous Cell Cancer of Head and Neck (SCCHN), NSCLC, SCLC, Cervical Cancer Metastatic, Breast Cancer Metastatic, Endometrial Cancer, Ovarian Cancer, Urothelial Cancer, Sarcoma, Thyroid Cancer

Study phase:

Phase I

Physician name:

Sarina Piha-Paul

Department:

Investigational Cancer Therapeutics

For general questions about clinical trials:

1-877-632-6789